drugset / Trial / NCT01528306

A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa

NCT01528306

Phase 2 Withdrawn Healthpoint
RandomizedCrossoverQuadruple-blindTreatment

Summary

This is a pilot study designed to see if HP802-247, an investigational treatment with living human skin cells, helps to heal blisters or wounds in subjects with Dystrophic Epidermolysis Bullosa (DEB). The durability of the skin in healed wounds treated with HP802-247 will also be assessed.

Timeline

Start
2012-03
Primary completion
2013-03
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Subject HP802-247 Cell therapy Topical